Connection

Massimo Volpe to Angiotensin II Type 1 Receptor Blockers

Back to Details
This is a "connection" page, showing publications Massimo Volpe has written about Angiotensin II Type 1 Receptor Blockers.
Massimo Volpe
Connection Strength
3.047
Angiotensin II Type 1 Receptor Blockers
  1. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome? Int J Cardiol. 2020 12 15; 321:150-154.
    View in: PubMed
    Score: 0.568
  2. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):248-251.
    View in: PubMed
    Score: 0.565
  3. Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan. Cardiovasc Ther. 2018 Dec; 36(6):e12471.
    View in: PubMed
    Score: 0.504
  4. Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat. J Hypertens. 2018 09; 36(9):1902-1914.
    View in: PubMed
    Score: 0.497
  5. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):255-263.
    View in: PubMed
    Score: 0.457
  6. Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):243-253.
    View in: PubMed
    Score: 0.457
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.